Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ruth Carrico

Nurse Practitioner, Family Chicago, IL Nurse Practitioner

NPI 1447629639 CMS profile 10760603

Po Box 776351, Chicago, IL 60677

Open in the dashboard

General payments

$578,156

673 records reported · program years 2021–2025

Research payments

$2,311

Paid to them · 1 record reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,900 paid to institutions, not to them · program year 2021

Through program year 2025, Ruth Carrico of Chicago, IL is reported in the CMS Open Payments database as having received $578,156 across 673 general payments and $2,311 in research payments paid to them. Separately, studies naming them as principal investigator received $3,900 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $166,967 180
2024 General $202,627 228
2023 General $104,696 135
2022 General $65,160 101
2021 General $38,706 29
2021 Research $2,311 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ruth Carrico
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Ruth Carrico were reported at $166,967. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Ruth Carrico Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $38,706 $124 $35–$379 $132
2022 $65,160 $141 $44–$430 $149
2023 $104,696 $154 $49–$476 $160
2024 $202,627 $165 $51–$504 $164
2025 $166,967 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Pfizer Inc. $495,614 575 payments
  2. Sanofi Pasteur Inc. $27,833 15 payments
  3. GlaxoSmithKline, LLC. $16,718 20 payments
  4. Moderna TX, Inc. $11,966 28 payments
  5. Seqirus USA Inc $6,990 4 payments
  6. Novavax Inc $6,195 10 payments
  7. Pfizer International LLC $4,200 4 payments
  8. Valneva USA, Inc. $4,103 7 payments
  9. Ambu Inc. $2,376 1 payment
  10. Shionogi Inc $1,475 2 payments
  11. Other $687 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $351,254 155 payments
  2. Consulting Fee $112,502 53 payments
  3. Travel and Lodging $95,543 307 payments
  4. Food and Beverage $12,657 156 payments
  5. Honoraria $6,200 2 payments
Products named General payments · program years 2021–2025
  1. ABRYSVO $192,213 256 payments
  2. PREVNAR 20 Vaccines $106,567 158 payments
  3. COMIRNATY $51,302 63 payments
  4. PAXLOVID $41,810 29 payments
  5. PENBRAYA $32,663 24 payments
  6. PREVNAR 20 Vaccines $19,074 13 payments
  7. FLUZONE HIGH-DOSE $12,689 7 payments
  8. FLUCELVAX QUADRIVALENT $6,461 3 payments
  9. NOVAVAX COVID-19 VACCINE, ADJUVANTED $6,195 10 payments
  10. FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE $5,936 4 payments
  11. Other $19,175 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. F. Hoffmann-La Roche AG $2,311 1 payment

Records

674 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record